Spasmolyt Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Anticholinergic effects such as dry mouth, dyspepsia and constipation may occur during treatment with trospium chloride.
Very common (≥10%): Gastrointestinal system: dry mouth.
Common (≥1%): Gastrointestinal system: dyspepsia, constipation, abdominal pain, nausea.
Uncommon (<1%): Gastrointestinal system: flatulence, diarrhoea.
Cardiovascular system: tachycardia.
Central nervous system: headache.
Body as a whole: chest pain.
Rare (<0.1%): Urinary system: micturition disorders (e.g. formation of residual urine), urinary retention.
Vision disorders: disorders of accommodation (this applies in particular to patients who are hypermetropic and whose vision has not been adequately corrected).
Central nervous system: dizziness.
Skin: rash.
Musculoskeletal system: myalgia, arthralgia.
Very rare (<0.01%): Skin: angio-oedema.
Not known: Cardiovascular system: tachyarrhythmia.
Nervous system: hallucination, agitation, confusion.
Skin: pruritus, urticaria, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN).
Respiratory system: dyspnoea.
Body as a whole: asthenia.
Immune system: anaphylaxis.
Liver and biliary system: mild to moderate increase in serum transaminase levels.
These adverse effects occurred mostly in elderly patients and can be facilitated by neurological diseases and/or concomitant intake of other anticholinergic drugs.

View ADR Reporting Link

Spasmolyt Adverse Reactions

trospium chloride

Manufacturer:

Mylan Healthcare

Distributor:

Zuellig Pharma